Health Highlights: Feb. 4, 2009

ByABC News
February 4, 2009, 1:01 PM

Feb. 5 -- Here are some of the latest health and medical news developments, compiled by editors of HealthDay:

Children's Health Bill Gets House Approval

Four million more U.S. children will be eligible for government-sponsored health coverage under legislation approved Wednesday by the House of Representatives. President Barack Obama signed the measure into law late Wednesday afternoon.

Voting 290-135, the House approved spending an additional $32.8 billion for the State Children's Health Insurance Program (SCHIP), the Associated Press reported. The program, with about 7 million children now enrolled, includes children whose family income is too high for Medicaid but whose families have difficulty affording private insurance.

According to The New York Times, the new law permits states to cover legal immigrants -- among them, children under 21 and pregnant women.

Previously, legal immigrants had been barred from Medicaid and SCHIP for five years after arriving in the United States. The states may now cover those immigrants without the five-year delay, the newspaper said.

The U.S. Senate passed the SCHIP measure last week. To cover adding the additional children, the measure raises federal excise taxes on cigarettes by 62 cents, to $1.01 a pack, the wire service said.

Former President George W. Bush twice vetoed similar legislation.

-----

FDA Reviews Sepsis Drug Xigris

U.S. health officials are reviewing cases of serious bleeding in patients taking the drug Xigris, which is used to treat severe sepsis (bloodstream infection).

A recently published study showed that the injectable drug increased the risk of dangerous internal bleeding when taken by patients with a recent history of hemorrhages, the U.S. Food and Drug Administration said Wednesday, the Associated Press reported.

The study of 73 patients treated with the Eli Lilly drug found that serious bleeding occurred in 35 percent of patients with a history of bleeding problems, compared with 3.8 percent of other patients.